TOPAMAX (topiramate) intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
Latest Information Update: 28 Feb 2011
At a glance
- Drugs Topiramate (Primary)
- Indications Headache disorders; Migraine
- Focus Therapeutic Use
- Acronyms INTREPID
- Sponsors Ortho-McNeil
- 28 Feb 2011 Primary endpoint 'Headache-frequency' has not been met
- 30 Mar 2010 Actual number of patients added to 385 as reported by ClinicalTrials.gov.
- 30 Mar 2010 Actual end date added to 1 Aug 2007 as reported by ClinicalTrials.gov.